Tim-3+PD-1+CD8+ T cells represent the predominant subset of TILs and combined targeting of both Tim-3 and PD-1 pathways, rather than single targeting of either pathway, has been shown to effectively reverse T cell exhaustion and restore anti-tumor immunity44,45. This evidence concerns the gene HAVCR2 and neoplasm.